文献速递重症综合管理与镇静镇痛

重症COVID-19患者家属PTSD症状的长期患病率:一项延伸至ICU出院后18个月的系列随访研究

Long-term prevalence of PTSD symptom in family members of severe COVID-19 patients: a serial follow-up study extending to 18 months after ICU discharge.
PubMed 文献 · J Intensive Care · 2024-12-18
一句话结论重症COVID-19患者家属中至少一种PTSD相关症状持续至出院后18个月(26%),15%为迟发型,PTSD症状者HRQOL更低。

该前瞻性研究在东京一家三级大学医院纳入重症COVID-19 ICU患者家属,最终68人参与分析,用事件影响量表修订版(评分>24定义存在PTSD症状)在ICU出院后6、12、18个月评估PTSD症状,并评估焦虑抑郁、睡眠障碍和健康相关生活质量。结果显示26%的家属报告至少一种PTSD相关症状并持续至出院后18个月(6个月16%、12个月23%、18个月25%),15%的亚组表现为迟发型PTSD症状;有PTSD相关症状的家属HRQOL更低,尤其精神和社交维度。作者强调ICU出院后对家属长期支持的重要性。

要点

  • 重症COVID-19患者家属中26%报告至少一种PTSD相关症状,持续至ICU出院后18个月。
  • PTSD相关症状患病率随时间变化:6个月16%、12个月23%、18个月25%。
  • 15%的家属亚组表现为迟发型PTSD症状,出院后12个月内未出现而后期出现。
  • 有PTSD相关症状的家属HRQOL更低,尤其精神和社交维度。
  • 作者强调ICU出院后对家属长期支持的重要性。

适用人群与场景

  • 东京一家三级大学医院重症COVID-19 ICU患者的家属,纳入时间为2020年7月至2022年6月,最终随访至2023年12月。
  • 共97名家属入组,68名参与分析。

诊断标准与关键阈值

  • PTSD症状采用事件影响量表修订版评估,评分>24定义为存在PTSD症状。

研究设计与关键结果

  • 前瞻性研究,纳入97名家属,68名参与;在ICU出院后6、12、18个月评估PTSD症状(事件影响量表修订版评分>24)、焦虑抑郁、睡眠障碍和HRQOL。
  • 26%的家属报告至少一种PTSD相关症状并持续至出院后18个月(6个月16%、12个月23%、18个月25%)。
  • 15%的家属亚组表现为迟发型PTSD症状。
  • 有PTSD相关症状的家属报告HRQOL更低,尤其精神和社交维度。

证据类型、等级与局限

  • 证据类型:前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者强调,鉴于重症COVID-19患者家属中PTSD相关症状持续存在,ICU出院后对家属的长期支持很重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Experiencing a loved one's stay in the intensive care unit (ICU) can profoundly affect families, often leading to post-intensive care syndrome-family (PICS-F), a condition particularly exacerbated during the COVID-19 pandemic. While PICS-F significantly impacts the mental health of families of ICU patients, especially in the context of COVID-19, the long-term effects beyond 12 months remain understudied. This study aims to explore the prevalence of PTSD-related symptoms and health-related quality of life (HRQOL) in family members up to 18 months after ICU discharge.

METHODS: This prospective study, conducted in a tertiary university hospital in Tokyo, enrolled family members of severe COVID-19 ICU patients (July 2020 to June 2022 with final follow-up ending in December 2023). The primary outcome was family member symptoms of PTSD at 6, 12 and 18 months after ICU discharge, measured by the Impact of Events Scale-Revised (presence of PTSD symptoms defined by score > 24). Secondary outcomes were family member symptoms of anxiety and depression, sleep disorders, and health-related quality of life (HRQOL) at the same timepoint.

RESULTS: Among 97 enrolled family members, 68 participated. At least one PTSD-related symptom was reported by 26% of family members, persisting over 18 months post-discharge (16% at 6 months, 23% at 12 months, and 25% at 18 months). A subgroup (15%) exhibited delayed-onset PTSD symptoms. Family members with PTSD-related symptoms reported lower HRQOL, especially in mental and social components.

CONCLUSIONS: The study underscores the importance of long-term support for family members post-ICU discharge, given the sustained prevalence of PTSD-related symptoms among family members of severe COVID-19 patients.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Nosaka N, Noguchi A, Takeuchi T, et al. Long-term prevalence of PTSD symptom in family members of severe COVID-19 patients: a serial follow-up study extending to 18 months after ICU discharge. J Intensive Care. 2024. PMID: 39695911. doi:10.1186/s40560-024-00765-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。